AUTUMN SINGHA: Open Payments
NPI 1730865296 · PASADENA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,803 in 61 payments from 21 companies in 2025. Trend: 2023 $93 · 2024 $1,824 · 2025 $1,803
Food & beverage: $1,803
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $330 |
| Octapharma USA, Inc. | 1 | $256 |
| Janssen Biotech, Inc. | 3 | $131 |
| Otsuka America Pharmaceutical, Inc. | 5 | $111 |
| Lundbeck LLC | 4 | $101 |
| Novartis Pharmaceuticals Corporation | 4 | $97 |
| PFIZER INC. | 4 | $93 |
| Axsome Therapeutics, Inc. | 3 | $79 |
| HARMONY BIOSCIENCES LLC | 3 | $68 |
| Biogen, Inc. | 2 | $63 |
Products named: OCTAGAM IMMUNE GLOBULIN (HUMAN), REXULTI, KESIMPTA, NURTEC ODT, VYALEV, UBRELVY, QULIPTA, WAKIX.
Industry payments across TX — which companies pay providers there.
